LINTERPHARMA
ActiveSummary
LINTERPHARMA has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €244,707. Equity is growing by ~19.6% per year across the filed fiscal years. Its solvency ranks better than 82% of 10485 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability87▲+2
Solvency96▼-4
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100,000 at 30 days acceptable
Liquidity ample (current ratio 4.62 against 7.14 in 2024; short-term debt: 13.2% and cash: 31.8% of total assets), and 28.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.3%
Return on assets
15%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 d early
2024
37 d early
2023
15 d early
2022
6 d early
2021
17 d early
2020
33 d early
2019
14 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 19 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#1 company by equity in Linter, Wholesale and retail trade sector#3 company by total assets in Linter, Wholesale and retail trade sector#3 oldest company in Linter, Wholesale and retail trade sector
Equity
€1.2m▼ 30.6%
2024 · €1.7m
Total assets
€1.6m▼ 25.5%
2024 · €2.2m
Net result
€244,707▼ 14.8%
2024 · €287,191
Working capital
€784,127▼ 37.5%
2024 · €1.3m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€401,703▲ 11.6%€340,292▼ 15.3%€449,113▲ 32.0%€400,484▼ 10.8%€323,282▼ 19.3%
Net result€269,609above the sector's middle half▲ 11.7%€252,472above the sector's middle half▼ 6.4%€330,963above the sector's middle half▲ 31.1%€287,191above the sector's middle half▼ 13.2%€244,707above the sector's middle half▼ 14.8%
Equity€1.1mabove the sector's middle half▲ 30.0%€1.2mabove the sector's middle half▲ 5.8%€1.5mabove the sector's middle half▲ 26.5%€1.7mabove the sector's middle half▲ 13.0%€1.2mabove the sector's middle half▼ 30.6%
Total assets€1.6mabove the sector's middle half▲ 18.6%€2.1mabove the sector's middle half▲ 29.2%€2.0mabove the sector's middle half▼ 1.6%€2.2mabove the sector's middle half▲ 7.1%€1.6mabove the sector's middle half▼ 25.5%
Debt€501,149▼ 0.7%€906,478▲ 80.9%€562,502▼ 37.9%€514,489▼ 8.5%€469,274▼ 8.8%
Working capital€955,647▲ 37.5%€957,918▲ 0.2%€1.1m▲ 17.6%€1.3m▲ 11.3%€784,127▼ 37.5%
Solvency68.9%above the sector's middle half▲ 6.1pp56.4%within the sector's middle half▼ 12.5pp72.5%above the sector's middle half▲ 16.1pp76.5%above the sector's middle half▲ 4.0pp71.3%above the sector's middle half▼ 5.3pp
Staff (FTE)2.2within the sector's middle half▼ 12.0%1.5below the sector's middle half▼ 31.8%0.6below the sector's middle half▼ 60.0%0below the sector's middle half▼ 100%0below the sector's middle half
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 19% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.6m
Fixed assets
€633,781 ▼ 13.8%
Current assets
€1.0m ▼ 31.4%
Equity and liabilities €1.6m
Equity
€1.2m ▼ 30.6%
Debt
€469,274 ▼ 8.8%
Debt's share of the balance-sheet total rises from 23.5% to 28.7%. Equity and debt are lower.
Key figures and ratios
EBITDA
€435,353▼
2024 · €505,953
Cash flow
€356,779▼
2024 · €392,660
Current ratio
4.62▼
2024 · 7.14
Quick ratio
3.32▼
2024 · 5.65
Debt to equity
0.40▲
2024 · 0.31
ROE
21.0%▲
2024 · 17.1%
ROA
15.0%▲
2024 · 13.1%
Interest coverage
34.13▼
2024 · 37.73
Debt ≤ 1 year
€216,325▲
2024 · €204,304
Debt > 1 year
€251,274▼
2024 · €289,787
Income taxes
€78,534▼
2024 · €101,000
Staff costs
€2,799▲
2024 · €2,357
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,082 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,082 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €96,969 | €23,091 | €0 | ▼ 100% |
| Remuneration, social security and pensions62 | €63,320 | €65,738 | €46,518 | €2,357 | €2,799 | ▲ 18.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €44,111 | €46,829 | €82,903 | €105,469 | €112,071 | ▲ 6.3% |
| Other operating charges640/8 | €3,661 | €3,810 | €3,662 | €6,993 | €1,313 | ▼ 81.2% |
| Non-recurring operating charges66A | - | €3,671 | €0 | - | - | - |
| Gross operating margin9900 | €512,795 | €460,340 | €582,196 | €515,303 | €439,466 | ▼ 14.7% |
| Operating profit (loss)9901 | €401,703 | €340,292 | €449,113 | €400,484 | €323,282 | ▼ 19.3% |
| Financial income75/76B | €7 | €301 | €6 | €1,117 | €12,714 | ▲ 1,038% |
| Recurring financial income75 | €7 | €301 | €6 | €1,117 | €12,714 | ▲ 1,038% |
| Financial charges65/66B | €10,502 | €11,401 | €20,529 | €13,410 | €12,754 | ▼ 4.9% |
| Recurring financial charges65 | €10,502 | €11,401 | €20,529 | €13,410 | €12,754 | ▼ 4.9% |
| Profit (loss) for the period before taxes9903 | €391,208 | €329,191 | €428,591 | €388,191 | €323,242 | ▼ 16.7% |
| Income taxes67/77 | €121,600 | €76,719 | €97,627 | €101,000 | €78,534 | ▼ 22.2% |
| Profit (loss) for the period9904 | €269,609 | €252,472 | €330,963 | €287,191 | €244,707 | ▼ 14.8% |
| Profit (loss) for the period to be appropriated9905 | €269,609 | €252,472 | €330,963 | €287,191 | €244,707 | ▼ 14.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.6m | €2.1m | €2.0m | €2.2m | €1.6m | ▼ 25.5% |
| Fixed assets21/28 | €472,341 | €867,216 | €715,232 | €735,593 | €633,781 | ▼ 13.8% |
| Tangible fixed assets22/27 | €467,266 | €862,141 | €710,157 | €730,518 | €628,781 | ▼ 13.9% |
| Land and buildings22 | €408,845 | €391,798 | €5,063 | €2,479 | €5,337 | ▲ 115% |
| Plant, machinery and equipment23 | €16,883 | €92,775 | €120,507 | €121,513 | €106,254 | ▼ 12.6% |
| Furniture and vehicles24 | €41,538 | €377,569 | €584,587 | €606,527 | €517,191 | ▼ 14.7% |
| Financial fixed assets28 | €5,075 | €5,075 | €5,075 | €5,075 | €5,000 | ▼ 1.5% |
| Current assets29/58 | €1.1m | €1.2m | €1.3m | €1.5m | €1.0m | ▼ 31.4% |
| Stocks and contracts in progress3 | €231,177 | €235,703 | €275,572 | €304,158 | €282,545 | ▼ 7.1% |
| Stocks30/36 | €231,177 | €235,703 | €275,572 | €304,158 | €282,545 | ▼ 7.1% |
| Amounts receivable within one year40/41 | €204,353 | €317,569 | €255,081 | €198,076 | €167,376 | ▼ 15.5% |
| Trade receivables40 | €158,109 | €169,860 | €187,402 | €190,192 | €158,131 | ▼ 16.9% |
| Other amounts receivable41 | €46,243 | €147,709 | €67,679 | €7,884 | €9,245 | ▲ 17.3% |
| Current investments50/53 | - | - | - | €500,000 | €0 | ▼ 100% |
| Cash at bank and in hand54/58 | €674,826 | €633,491 | €778,217 | €419,544 | €520,503 | ▲ 24.1% |
| Deferred charges and accrued income490/1 | €28,489 | €27,229 | €24,564 | €36,333 | €30,027 | ▼ 17.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.6m | €2.1m | €2.0m | €2.2m | €1.6m | ▼ 25.5% |
| Equity10/15 | €1.1m | €1.2m | €1.5m | €1.7m | €1.2m | ▼ 30.6% |
| Contributions10/11 | €8,676 | €8,676 | €8,676 | €8,676 | €8,676 | = |
| Reserves13 | €1.1m | €1.2m | €1.5m | €1.7m | €1.2m | ▼ 30.8% |
| Non-distributable reserves130/1 | €6,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Reserves not available under the articles1311 | €6,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Tax-exempt reserves132 | €37,500 | €37,500 | €37,500 | €37,500 | €37,500 | = |
| Distributable reserves133 | €1.1m | €1.1m | €1.4m | €1.6m | €1.1m | ▼ 31.5% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €501,149 | €906,478 | €562,502 | €514,489 | €469,274 | ▼ 8.8% |
| Amounts payable after more than one year17 | €301,062 | €632,259 | €327,399 | €289,787 | €251,274 | ▼ 13.3% |
| Financial debts170/4 | €301,062 | €632,259 | €327,399 | €289,787 | €251,274 | ▼ 13.3% |
| Amounts payable within one year42/48 | €183,198 | €256,074 | €207,259 | €204,304 | €216,325 | ▲ 5.9% |
| Current portion of amounts payable after more than one year42 | €32,567 | €69,073 | €37,081 | €37,807 | €38,729 | ▲ 2.4% |
| Trade debts44 | €105,485 | €158,555 | €135,935 | €157,552 | €154,770 | ▼ 1.8% |
| Suppliers440/4 | €105,485 | €158,555 | €135,935 | €157,552 | €154,770 | ▼ 1.8% |
| Taxes, remuneration and social security45 | €29,069 | €7,564 | €14,030 | €1,886 | €2,898 | ▲ 53.6% |
| Taxes450/3 | €21,496 | - | €13,292 | €1,886 | €2,898 | ▲ 53.6% |
| Remuneration and social security454/9 | €7,573 | €7,564 | €737 | €0 | - | - |
| Other amounts payable47/48 | €16,078 | €20,882 | €20,215 | €7,060 | €19,929 | ▲ 182% |
| Accrued charges and deferred income492/3 | €16,888 | €18,146 | €27,844 | €20,398 | €1,676 | ▼ 91.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €269,609 | €252,472 | €330,963 | €287,191 | €244,707 | ▼ 14.8% |
| + Depreciation and write-downs630 | €44,111 | €46,829 | €82,903 | €105,469 | €112,071 | ▲ 6.3% |
| Operating cash flow (approximation) | €313,719 | €299,301 | €413,867 | €392,660 | €356,779 | ▼ 9.1% |
| Investment in fixed assets (approximation) | - | -€441,704 | €69,081 | -€125,830 | -€10,260 | ▲ 91.8% |
| Change in cash | - | -€41,336 | €144,726 | -€358,672 | €100,959 | ▲ 128% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
09-07
State Gazette act
Resignation: Ingrid Catfolis (director)Appointment: Apotheker Laura Spiritus BV (director) · Permanent representative: Laura Spiritus6 facts ▸
State Gazette act
Resignation: Ingrid Catfolis (director)
Appointment: Apotheker Laura Spiritus BV (director) · Permanent representative: Laura Spiritus6 facts ▸
- General meeting, 29-01-2026
- Director resignation, Ingrid Catfolis (director)
- Director appointment, Apotheker Laura Spiritus BV (director)
- Permanent representative, Laura Spiritus (permanent representative)
- Board meeting, 29-01-2026
- Director in office, Ingrid Catfolis (director)
2025
24-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €330,963 ▲31.1%
Operating result €449,113, net result €330,963, both a record.
25-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
14-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Equity above €1mEq €1.1m ▲30%
4 profitable years in a row build equity to €1.1m.
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Weakest financial yearnet €241,380 ▼2.7%
Net result drops to €241,380, the lowest in the series; recovery starts the following year.
17-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
07-05
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 4 acts read
About the unread acts
Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Board 1
APOTHEKER LAURA SPIRITUS
CurrentDirector · since 01-02-2026 · Private limited company · perm. rep.: Laura Spiritus
Permanent representatives 1
Laura Spiritus
CurrentPermanent representative · since 01-02-2026 · for APOTHEKER LAURA SPIRITUS
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
3 of this company's 4 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Linter · 1 establishment unit since 1984
Ground area
1,552 m²
Building footprint
382 m²
Parcel 24022D0289/00H000, Flanders. Linked by address, not a title deed.
1 establishment unit
Grote Steenweg(DRL) 302, 3350 Linter
since 19842.025.069.097
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24022D0289/00H000 | Flanders | 1,552 m² | 1 · 382 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
2 people since 2026, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| APOTHEKER LAURA SPIRITUS |
|
| Ingrid Catfolis |
|
Structure & network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Recognitions · licences · registrations
Food safety, FASFC
1 siteLinter2.025.069.097
Similar companies · same sector, comparable size
Apotheek de Lisseweg
BE 0419.097.309
Izegem · Eq €1,166,454
SEBASTIAAN
BE 0449.096.340
Linkebeek · Eq €1,163,424
PHARMA BIEN-ÊTRE
BE 0776.600.905
Namur · Eq €1,167,257
PHARMACIE DENAMUR
BE 0508.898.820
Viroinval · Eq €1,162,207
PHARMALAW
BE 0679.616.642
Anderlecht · Eq €1,167,795
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 2,899 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded26-07-1984
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0426079824
Also
9925:BE0426079824
Registered
10-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.